Publication Name	World Journal of Clinical Cases
Manuscript ID	76958
Country	China

Received	2022-04-24 15:34
Peer-Review Started	2022-04-22 04:45
To Make the First Decision
Return for Revision	2022-06-08 08:54
Revised	2022-06-17 12:16
Second Decision	2022-08-22 03:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-08-25 20:45
Articles in Press	2022-08-25 20:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-09-14 08:28
Publish the Manuscript Online	2022-09-27 13:00

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Case Report
Article Title	Tislelizumab-related enteritis successfully treated with adalimumab: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Na Chen, Min-Jia Qian, Ru-Hui Zhang, Qi-Qi Gao, Chao-Chao He, Ya-Ke Yao, Jian-Ying Zhou and Hua Zhou
ORCID	Author(s) ORCID Number Ru-Hui Zhang http://orcid.org/0000-0002-1553-8538 Jian-Ying Zhou http://orcid.org/0000-0002-8924-935X Hua Zhou http://orcid.org/0000-0001-6397-3203
Funding Agency and Grant Number
Corresponding Author	Hua Zhou, MD, Associate Chief Physician, Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Qingchun Road 79, Hangzhou 310003, China. zhouhua1@zju.edu.cn
Key Words	Tislelizumab; Adalimumab; Enteritis; Case report
Core Tip	A patient with advanced lung cancer who developed diarrhea after receiving tislelizumab combined with pemetrexed and carboplatin, with poor response to glucocorticoid treatment. The symptoms were significantly improved after the use of adalimumab 10 mg, subcutaneous injection, every 2 wk for 3 times. Colonoscopy and intestinal mucosal pathology suggested improvement.
Publish Date	2022-09-27 13:00
Citation	Chen N, Qian MJ, Zhang RH, Gao QQ, He CC, Yao YK, Zhou JY, Zhou H. Tislelizumab-related enteritis successfully treated with adalimumab: A case report. World J Clin Cases 2022; 10(28): 10186-10192
URL	https://www.wjgnet.com/2307-8960/full/v10/i28/10186.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i28.10186

Full Article (PDF)	WJCC-10-10186.pdf
Full Article (Word)	WJCC-10-10186.docx
CARE Checklist–2016	76958-CARE-Checklist–2016-revision.pdf
Manuscript File	76958_Auto_Edited-YXX-LS.docx
Answering Reviewers	76958-Answering reviewers.pdf
Audio Core Tip	76958-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	76958-Conflict-of-interest statement.pdf
Copyright License Agreement	76958-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	76958-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	76958-Language certificate.pdf
Peer-review Report	76958-Peer-review(s).pdf
Scientific Misconduct Check	76958-Bing Xing YX-2.png
Scientific Editor Work List	76958-Scientific editor work list.pdf